Drug Shortage Report for GD-AZITHROMYCIN

Last updated on 2018-08-15 History
Report ID 27753
Drug Identification Number 02274566
Brand name GD-AZITHROMYCIN
Common or Proper name AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 300mg/15mL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-17
Estimated end date
Actual end date 2018-08-14
Shortage status Resolved
Updated date 2018-08-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-11-01 English Compare
v2 2017-11-01 French Compare
v3 2017-12-18 English Compare
v4 2017-12-18 French Compare
v5 2018-01-09 English Compare
v6 2018-01-19 English Compare
v7 2018-01-19 French Compare
v8 2018-02-13 English Compare
v9 2018-02-13 French Compare
v10 2018-02-21 English Compare
v11 2018-02-21 French Compare
v12 2018-05-17 English Compare
v13 2018-05-17 French Compare
v14 2018-08-14 English Compare
v15 2018-08-14 French Compare
v16 2018-08-15 English Compare

Showing 1 to 16 of 16